Download PDF
Zeitschrift für Komplementärmedizin 2014; 06(01): 50-53
DOI: 10.1055/s-0034-1368129
zkm | Wissen
Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart

Aderlass

Grundlagen, Wirkmechanismen und praktisches Vorgehen
Andreas Michalsen
Further Information

Publication History

Publication Date:
07 March 2014 (online)

    Permissions and Reprints

Keywords:

Aderlass - Refresher - Mikroaderlass - systemischer Aderlass - lokaler Aderlass
 

  • Literatur

  • 1 Adams SL.. The medicinal leech. A page from the annelids of internal medicine.. Ann Internal Med 1988; 109: 399-405
    CrossrefGoogle Scholar
  • 2 Danesh J, Applebie P.. Coronary artery disease and iron status. Meta-analysis of prospective studies.. Circulation 1999; 99: 852-855
    CrossrefGoogle Scholar
  • 3 De Felice M, Gallo P, Masotti G.. Current therapy of peripheral artery disease. The non-surgical approach.. Angiology 1990; 1: 1-11
    Google Scholar
  • 4 Ernst E, Kollar L, Matrai A.. A placebo-controlled double blind study of hemodilution in peripheral artery disease.. Lancet 1987; II: 1449-1451
    Google Scholar
  • 5 Fernandez-Real JM, Lopez-Bermejo A, Ricart W.. Cross-talk between iron metabolism and diabetes.. Diabetes 2002; 51 ((8)) 2348-2354
    CrossrefPubMedGoogle Scholar
  • 6 Fernandez-Real JM, Penarroja G, Castro A et al. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function.. Diabetes 2002; 51 ((4)) 1000-1004
    CrossrefGoogle Scholar
  • 7 Fernandez-Real JM, Penarroja G, Castro A et al. Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity.. Diabetes Care 2002; 25 ((12)) 2249-225
    CrossrefGoogle Scholar
  • 8 Houschyar KS, Lüdtke R, Dobos GJ et al. Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial.. BMC Medicine 2012; 10 (54)
    Google Scholar
  • 9 Kiesewetter H.. Therapeutische Hämatokritsenkung.. DMW 1988; 113: 484
    Google Scholar
  • 10 Kiesewetter H, Jung F, Spitzer S et al. Die Fließeigenschaften des Blutes und ihre klinische Bedeutung beim Gefäßpatienten.. Internist 1989; 30: 420-428
    Google Scholar
  • 11 Michalsen A. Aderlaß. Darf man wieder zur Ader lassen?. Z Allg Med 1996; 72: 894-899
    Google Scholar
  • 12 Michalsen A. Aderlaß. In: Bühring M, Kemper FH, eds. Naturheilverfahren und unkonventionelle Medizinische Richtungen.. Berlin, Heidelberg:: Springer, Loseblattsysteme; 1994
    CrossrefGoogle Scholar
  • 13 Niasari M, Kosari F, Ahmadi A.. The effect of wet cupping on serum lipid concentrations of clinically healthy young men: a randomized controlled trial.. J Altern Complement Med 2007; 13 ((1)) 79-82
    CrossrefGoogle Scholar
  • 14 Rotschuh KE.. Konzepte der Medizin in Vergangenheit und Gegenwart.. Stuttgart:: Hippokrates; 1978
    Google Scholar
  • 15 Salonen JT, Tuomainen TP, Salonen R et al. Donation of blood is associated with reduced risk of myocardial infarction. The Kuopio Ischaemic Heart Disease Risk Factor Study.. Am J Epidemiol 1998; 148 ((5)) 445-451
    CrossrefGoogle Scholar
  • 16 Salonen JT, Korpela H, Nyyssonen K et al. Lowering of body iron stores by blood letting and oxidation resistance of serum lipoproteins: a randomized cross-over trial in male smokers.. J Intern Med 1995; 237 ((2)) 161-168
    CrossrefGoogle Scholar
  • 17 Salonen JT, Nyyssonen K, Salonen R.. Body iron stores and the risk of coronary heart disease.. N Engl J Med 1994; 331 ((17)) 1159; author reply 1160
    Google Scholar
  • 18 Schmid-Schönbein H, Messmer K, Rieger H.. Hemodilution and flow improvement.. Basel:: Karger;; 1981
    Google Scholar
  • 19 Sumida Y, Kanemasa K, Fukumoto K et al. Effects of dietary iron reduction versus phlebotomy in patients with chronic hepatitis C: results from a randomized, controlled trial on 40 Japanese patients.. Intern Med 2007; 46 ((10)) 637-642
    CrossrefGoogle Scholar
  • 20 Thiele G, Bürkmann I, Zeisenheim K et al. Die isovolämische Hämodilution – ein adjuvantes Behandlungsprinzip bei Patienten mit Cor pulmonale.. Z Ges inn Med 1990; 45: 315-318
    Google Scholar
  • 21 Zacharski LR, Chow BK, Howes PS et al. Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial.. JAMA 2007; 297 ((6)) 603-610
    CrossrefGoogle Scholar
  • 22 Zacharski LR, Chow B, Lavori PW et al. The iron (Fe) and atherosclerosis study (FeAST): a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease.. Am Heart J 2000; 139 ((2 Pt 1)) 337-345
    Google Scholar
  • 23 Zanoni G, Leutenegger F.. Die Auswirkungen von Volumenmanipulation (Aderlaß) auf die Drucke im Niederdrucksystem und auf den Hämatokrit.. Schweiz Med Wschr 1975; 105: 1456-1410
    Google Scholar
  • 24 Zidek W, Tenschert W, Karoff C et al. Treatment of resistant hypertension by phlebotomy.. Klin Wochenschr 1985; 63: 762-764
    CrossrefGoogle Scholar
  • 25 Zacharski LR.. Hemochromatosis, iron toxicity and disease.. J Intern Med 2010; 268: 246-248
    CrossrefGoogle Scholar